| Having trouble reading this newsletter? Click here to see it in your browser. You are receiving this newsletter because you signed up from our web site. Click here to unsubscribe. |
 10 February 2009  |
 |
|
Dealmakers Newsletter Update: M&A specialSponsored this month by: Anti-Infectives Partnering & Deal-Making Summit Boston, MA, USA - March 5-6, 2009 An infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives Visit the conference website for further details.
Editor's cornerWelcome to the new-look Dealmakers newsletter from CurrentPartnering. This month we are focussing on M&A deals to reflect the large amount of activity in the first weeks of 2009: - several major M&A deals announced - bigpharma CEOs making noise about M&A/partnering for 2009 We have updated our M&A report to reflect this latest activity, incorporating deals up to and including end 2008 - more details below. In addition, we have updated our co-promotion/co-marketing report. These join our ever expanding list of titles. All for now -- Steve Poile -- New this monthRevised and updated reports: CurrentPartnering has revised and updated its most popular reports: Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition The Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 2nd edition New report: CurrentPartnering has launched its latest report: Royalty Financing Agreements in Pharma, Biotech and Diagnostics The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals. New from Datamonitor: Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape Since the financial meltdown, the relationship between Pharma and Biotech has been turned on its head. Previously, pharma companies had no choice but to license Biotech drugs at high prices in order to fill their sparse late stage pipelines Partnering roundupA clutch of bigpharma CEOs have been making noises about the need for M&A and partnering in 2009 - here are just a few of them:
Of course the one confirmed M&A deal of 2009 made plenty of news: Other stories emerging in recent weeks:
In the newsThe early weeks of 2009 have been filled with M&A announcements:
Other deals of note so far in 2009:
Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature Best practice articlesOnline webcast: A better way to conduct alliance management An exclusive webcast that brings together alliance managers to share their experiences in building and maintaining successful partnerships Through acquiring Wyeth, Pfizer will secure place as world’s biggest prescription pharma company to 2013 The merger/acquisition of Wyeth by Pfizer will create a prescription pharmaceutical company of unprecedented industry scale, enhancing Pfizer’s status as the sector’s leading player - more Small, Fully Integrated, Operating Worldwide, An Oxymoron Not if you are a urology specialist like Apogepha Arzneimittel GmbH! - more BIO-Europe Spring Receives Major Endorsement from Italian Bio-Pharma Industry EBD Group has announced that BIO-Europe Spring® 2009, March 16–18, 2009 at the Milano Convention Centre (MIC), Milan, Italy, has received the enthusiastic support of the Italian bio-pharma industry - more Read all our partnering best practice articles. Forthcoming eventsHere are some of our suggested events for spring 2009: EuroPLX 39 Lisbon Cascais (near Lisbon), Portugal - March 2-3, 2009 - more details 6th Anti-Infectives Partnering & Deal Making-Summit Boston, MA, USA - March 5-6, 2009 - more details BioEurope Spring 2009 Milan, Italy - March 16-18, 2009 - more details BIO-Windhover 2009 New York, USA - April 13-15, 2009 - more details Pharmaceutical Strategic Outlook 2009 The Grand Hyatt New York City, USA - April 13-15, 2009 - more details CHI Alliance Management Congress Boston, MA, USA - April 22-23, 2009 - more details BIO International Convention 2009 Atlanta, GA, USA, May 18-21, 2009 - more details Euro-Biotech Forum 2009 Barcelona, Spain, June 30 to July 1, 2009 - more details People on the moveThe following people have been reported on the move during the early weeks of 2009: Jim Rurka, Stephen Ciesinski, Peter Johnson, Al Rosenston, Vincent Mihalik , Gary Thompson to name just a few read more about the latest people on the move If you have news about a business development executive who is on the move - let us know Partnering resourcesCurrent Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries. The following topic areas are available - updated regularly:
Missing something? Let us know and we will include all appropriate resources.
About CurrentPartneringCurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
Advertizing and sponsorshipCurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online. or contact us to discuss your requirements.
Contact usSteve Poile, Editor Web: http://www.CurrentPartnering.com Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom Tel: +44 7896 656732 Fax: +44 8703 305993
|
|
|
|
Sponsored by: 
CurrentPartnering reports
|
|
|
||
|
 |
|